Category: Heart (Cardiac)

Bucindolol Overview

Bucindolol is a non-selective beta blocker with additional weak alpha-blocking properties and some intrinsic sympathomimetic activity.[1][2] It was under review by the FDA in the United States for the treatment of heart failure in 2009, but was rejected due to issues pertaining to integrity of data submitted.[1][3] See also Beta blocker Primidolol References .mw-parser-output .reflist{font-size:90%;margin-bottom:0.5em;list-s...

Read more Bucindolol Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Bucindolol

Recent Bucindolol Forums:

Be the first to start a discussion about this drug.